NovaMed Pharmaceuticals

Focus: NovaMed Pharmaceuticals is a small molecule-focused pharmaceutical company headquartered in Lahore, Pakistan, specializing in neurology therapeutics. Limited public data suggests an emerging or early-stage regional player.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About NovaMed Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow NovaMed Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

18 Transdermal patches along with positive and negative controls 1)Capsaicin0.025% Topical Patch, 2)Diclofenac Diethylamine 100mg Transdermal Patch, 3)Diclofenac Diethylamine 200mg Transdermal Patch,

Healthy Participants

N/A

Clinical Trials (1)

NCT07060976To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

N/A

Help build intelligence for NovaMed Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage neurology focus in an underserved market with potential for meaningful therapeutic impact
Opportunity to build organizational infrastructure and establish processes at a formative stage
Regional headquarters in Pakistan may offer cost-of-living advantages and emerging market growth exposure

Watch Out For

No active job openings reported, suggesting minimal current hiring or organizational dormancy
Absence of published clinical trials, revenue, or documented pipeline raises visibility and validation concerns
Limited financial, funding, or public market data creates uncertainty about sustainability and growth trajectory

Generated by Claude from NovaMed Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

lipoic acid

Diabetics

Phase 2/3

Clinical Trials (1)

NCT01224353Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy

Phase 2/3

Budesonide dry powder inhaler

Asthma

Phase 2/3

Clinical Trials (1)

NCT01269437Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Phase 2/3

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 3 clinical trials

Top TAs: Respiratory

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Respiratory

1 pipeline

Marketed

Pipeline